It’s called the “stealth” variant, but there’s nothing particularly stealthy about it. Researchers are working to parse whether it is a new threat.
As coronavirus case numbers in the U.S. show early signs of tapering, scientists are keeping a watchful eye on a newly identified version of the omicron variant, nicknamed “stealth omicron,” that is driving new outbreaks in parts of Europe.
The culprit is a “subvariant” of the omicron variant, which means it’s closely related to omicron but has some different mutations. Known officially as BA.2, the subtype has small variations that set it apart from the original omicron strain but not enough for it to be considered an entirely new lineage.
“You could say they’re like brothers in the same family,” said infectious diseases expert Cameron Wolfe, an associate professor of medicine at the Duke University School of Medicine. “There are some subtle differences, but most of the genetics are the same in both.”
Researchers are trying to learn as much as they can about BA.2; here’s what’s known about it so far.
Why is it known as ‘stealth’ omicron?
Unlike what its nickname might suggest, the BA.2 subtype isn’t known as “stealth” omicron because it’s difficult to find.
The nickname comes from a shortcut that helped researchers quickly identify omicron in PCR tests.
Because of a quirk in omicron’s genetic sequence, PCR test results looked different from typical positive tests, essentially providing researchers with an easy way to spot the variant without sequencing the samples. (PCR tests generally aren’t used to determine what variant people have, only whether they are infected with the coronavirus.)
One of BA.2’s mutations got rid of the genetic quirk, meaning that shortcut is no longer available.
“So now when you get a readout for BA.2, it says: Yes, Covid is here, but we don’t know what type it is,” Wolfe said.
With omicron now accounting for more than 99 percent of new reported Covid-19 cases in the U.S., the distinction isn’t a huge issue, Wolfe said, and it doesn’t affect how infections are dealt with in clinical settings.
It was more important last month, as omicron was gaining steam in relation to the delta variant, because monoclonal antibodies were found to be less effective to treat omicron, he added.
“It was useful then to know if the person in front of me had delta and I could use monoclonal antibodies or if they had omicron and I shouldn’t,” Wolfe said.
What is different about BA.2?
The BA.2 subvariant most likely evolved as omicron circulated widely around the world. As a virus spreads and replicates, it naturally picks up random mutations that can change how it behaves, such as how contagious it is or how severely it can make people ill — although many mutations won’t change how the virus affects humans.
It’s too soon to know for sure, but there are concerns that the specific mutations identified with the BA.2 subtype could make it more contagious or better able to evade vaccines — two factors that had already enabled the omicron variant to spread so pervasively around the globe.
The original omicron strain, known as BA.1, featured around 50 genetic mutations that separated it from the original strain of the coronavirus. Thirty-six of the mutations were to the virus’s spike proteins, which cover the outside of the virus and are the main targets of vaccines and treatments like monoclonal antibodies.
A study published in the Journal of Medical Virology on Dec. 29 found that the BA.2 subtype has 28 mutations in its spike proteins, several of them different from the original omicron strain.
The World Health Organization hasn’t yet classified BA.2 as a “variant of concern,” but it said its characteristics, “including immune escape properties and virulence, should be prioritized independently.”
Is it more contagious?
Preliminary research in Denmark, where cases involving BA.2 are rising, suggest that the subvariant may be more contagious than the original omicron strain, which was already the most transmissible known variant to date.
The BA.2 subtype accounted for 20 percent of Denmark’s Covid-19 cases at the end of December, and it jumped to 45 percent of reported cases by the second week of January. Danish Health Minister Magnus Heunicke said this week that the BA.2 subvariant is now dominant in the country.
That type of rapid growth could indicate that BA.2 is more contagious than the original omicron strain, but more research is needed.
Scientists in Denmark found the proportion of BA.2 cases rising across the country, including in regions where the original omicron strain was dominant. That seems to indicate that the new outbreaks aren’t just an anomaly, said Dr. Stuart Ray, a professor of medicine at Johns Hopkins University.
“That suggests that maybe BA.2 is displacing BA.1, like it’s really competing,” he said.
But Ray said much remains unknown about the situation in Denmark and whether BA.2 could cause a similar increase in cases in the U.S.
Does it cause more severe illness?
So far, there is no evidence to suggest that the subvariant causes more severe illness or symptoms, but it may be too soon to tell.
Danish health officials said in a news briefing Wednesday that while the BA.2 subtype seems more contagious, there are no indications that it has an impact on hospitalizations or deaths.
Still, hospitalizations and deaths from Covid-19 tend to lag behind infections.
“Severity takes some time to figure out, and it’s often murky,” Wolfe said. “When these things crop up again, they tend to affect younger, more mobile parts of the population first that might not end up in hospitals anyway because they’re otherwise fit and health.”
Are vaccines effective against the subvariant?
More research is needed, but early reports show that vaccines are roughly as effective against BA.2 as they are against the original strain of omicron.
While omicron’s mutations allowed it to better evade protective antibodies generated by vaccines and natural immunity, the vaccines and the booster shots protected the vast majority of people from becoming seriously ill.
And while the omicron variant caused less severe disease overall, the sheer number of infections during this wave is still placing a huge burden on hospitals across the country.
Dr. Dale Bratzler, the chair of the Department of Health Administration and Policy at the University of Oklahoma’s Hudson College of Public Health, said it’s reasonable to think the vaccines will hold up similarly well with the BA.2 subvariant. But he added that certain parts of the population will be more vulnerable than others, as has been the case throughout the pandemic.
“The people we always worry about are high-risk individuals above age 65, people who are immunosuppressed or have pre-existing conditions that could lead to severe complications from Covid,” he said.
He said it remains as important as ever to continue promoting vaccination efforts and to keep wearing masks to protect vulnerable people in the community.
Where has BA.2 been detected?
The omicron subvariant has been identified in several countries, including Denmark, the United Kingdom, Norway, India, the Philippines and South Africa.
In the U.S., BA.2 accounts for an extremely low percentage of newly reported cases, but it has already been detected in California, Washington, New York, Texas, Utah, New Mexico and other states.

News
Studies detail high rates of long COVID among healthcare, dental workers
Researchers have estimated approximately 8% of Americas have ever experienced long COVID, or lasting symptoms, following an acute COVID-19 infection. Now two recent international studies suggest that the percentage is much higher among healthcare workers [...]
Melting Arctic Ice May Unleash Ancient Deadly Diseases, Scientists Warn
Melting Arctic ice increases human and animal interactions, raising the risk of infectious disease spread. Researchers urge early intervention and surveillance. Climate change is opening new pathways for the spread of infectious diseases such [...]
Scientists May Have Found a Secret Weapon To Stop Pancreatic Cancer Before It Starts
Researchers at Cold Spring Harbor Laboratory have found that blocking the FGFR2 and EGFR genes can stop early-stage pancreatic cancer from progressing, offering a promising path toward prevention. Pancreatic cancer is expected to become [...]
Breakthrough Drug Restores Vision: Researchers Successfully Reverse Retinal Damage
Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one of the most important human senses, yet more than 300 million people around the world are at [...]
Differentiating cancerous and healthy cells through motion analysis
Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they are cancerous or healthy. They observed malignant fibrosarcoma cells and [...]
This Tiny Cellular Gate Could Be the Key to Curing Cancer – And Regrowing Hair
After more than five decades of mystery, scientists have finally unveiled the detailed structure and function of a long-theorized molecular machine in our mitochondria — the mitochondrial pyruvate carrier. This microscopic gatekeeper controls how [...]
Unlocking Vision’s Secrets: Researchers Reveal 3D Structure of Key Eye Protein
Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty acids and how its dysfunction may lead to retinal diseases. Proteins play a critical [...]
5 Key Facts About Nanoplastics and How They Affect the Human Body
Nanoplastics are typically defined as plastic particles smaller than 1000 nanometers. These particles are increasingly being detected in human tissues: they can bypass biological barriers, accumulate in organs, and may influence health in ways [...]
Measles Is Back: Doctors Warn of Dangerous Surge Across the U.S.
Parents are encouraged to contact their pediatrician if their child has been exposed to measles or is showing symptoms. Pediatric infectious disease experts are emphasizing the critical importance of measles vaccination, as the highly [...]
AI at the Speed of Light: How Silicon Photonics Are Reinventing Hardware
A cutting-edge AI acceleration platform powered by light rather than electricity could revolutionize how AI is trained and deployed. Using photonic integrated circuits made from advanced III-V semiconductors, researchers have developed a system that vastly [...]
A Grain of Brain, 523 Million Synapses, Most Complicated Neuroscience Experiment Ever Attempted
A team of over 150 scientists has achieved what once seemed impossible: a complete wiring and activity map of a tiny section of a mammalian brain. This feat, part of the MICrONS Project, rivals [...]
The Secret “Radar” Bacteria Use To Outsmart Their Enemies
A chemical radar allows bacteria to sense and eliminate predators. Investigating how microorganisms communicate deepens our understanding of the complex ecological interactions that shape our environment is an area of key focus for the [...]
Psychologists explore ethical issues associated with human-AI relationships
It's becoming increasingly commonplace for people to develop intimate, long-term relationships with artificial intelligence (AI) technologies. At their extreme, people have "married" their AI companions in non-legally binding ceremonies, and at least two people [...]
When You Lose Weight, Where Does It Actually Go?
Most health professionals lack a clear understanding of how body fat is lost, often subscribing to misconceptions like fat converting to energy or muscle. The truth is, fat is actually broken down into carbon [...]
How Everyday Plastics Quietly Turn Into DNA-Damaging Nanoparticles
The same unique structure that makes plastic so versatile also makes it susceptible to breaking down into harmful micro- and nanoscale particles. The world is saturated with trillions of microscopic and nanoscopic plastic particles, some smaller [...]
AI Outperforms Physicians in Real-World Urgent Care Decisions, Study Finds
The study, conducted at the virtual urgent care clinic Cedars-Sinai Connect in LA, compared recommendations given in about 500 visits of adult patients with relatively common symptoms – respiratory, urinary, eye, vaginal and dental. [...]